London - Imperial College
Imperial College ECMC aims to develop novel imaging, biomarker and therapeutic approaches for cancer, with a particular focus on reversing drug resistance and aiding personalised treatments. Other areas of expertise include metabolomics and epigenetics.
Tissue banking (particularly lung and ovarian cancer samples) is also conducted to underpin the Centre’s biomarker research.
Research Areas
Focus
Functional imaging, gene therapy, drug resistance
Disease Area
All malignancies; special focus on breast cancer, gynaecological cancers, lung cancer, prostate cancer
Goals
For further information on the goals and objectives of Imperial College ECMC go to:
Skills
Imperial College ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Imperial College ECMC has access to a range of research facilities that are utilised in studies.
Achievements
To learn more about the scientific and operational achievements of Imperial College ECMC go to:
Centre Lead
Professor Charles Coombes
Director
Department of Medical Oncology
Imperial College London
Faculty of Medicine
Hammersmith Hospital Campus
Imperial College, Du Cane Road
LONDON
W12 ONN
Clinical Trials Enquiries
You can also find out about trials recruiting in London on the CancerHelp UK clinical trials database.
Increase text
Decrease text
Print this page